Global Burden of Chronic Respiratory Diseases

Abstract

Background: Noncommunicable diseases (NCDs) and chronic respiratory diseases (CRDs) are the main causes of mortality and morbidity worldwide. Methods: The main evidences about the NCDs and CRDs burden and related risk factors, from updated international reports and results of original researches, were collected and described in this review. Results: Most recent evidence is available from the Global Burden of Diseases Study (GBD) 2017 reports. There were 3.2 million deaths due to chronic obstructive pulmonary disease (COPD) and 495,000 deaths due to asthma. COPD was the seventh leading cause of years of life lost (YLLs). Overall, prevalent cases of CRDs were 545 million: about 50% for COPD and 50% for asthma. Incident cases of CRDs were 62 million, mostly due to asthma (69%) and COPD (29%). COPD accounted for 81.6 million disability-adjusted life years, asthma for 22.8 million. COPD prevalence of 9.1% has been found in a recent general population sample of NorthEastern Italy, while in Central Italy a 25-year follow-up of a general population sample has shown an increased prevalence of COPD and asthma up to 6.8% and 7.8%, respectively. In Central Italy, a COPD incidence of 8% and an asthma incidence of 3.2% have been found in adult subjects at an 18-year follow-up. Among the risk factors, a relevant role is played by smoking and high body mass index for asthma, while smoking, particulate matter pollution, ambient ozone pollution, occupational exposure to particulate matter, gases and fumes, as well as secondhand smoke, play an important role for COPD. Forecasting the YLLs by 2040 indicates a rising toll from several NCDs due to population growth and aging, with COPD expected to reach the fourth leading cause. Conclusions: Several recent studies and international reports highlighted the huge global health burden of CRDs and other major NCDs, pointing out the need for implementing international collaborations to fight this epidemic trend.

A review of therapies for the overlap syndrome of obstructive sleep apnea and chronic obstructive pulmonary disease

“…23 In 2017, COPD led to 3.2 million deaths worldwide. 23 Over 90% of deaths from COPD are in low-and middle-income countries. 22 In 2017, COPD was seventh leading cause of years of life lost.…”

“…By 2040, it is expected to be the fourth leading cause. 23 Patients with COPD may suffer from a spectrum of SRBD, including OSA, sleep-related hypoventilation and central sleep apnea (CSA).…”

Extracorporeal membrane oxygenation—the good, the bad and the ugly (for want of a “few dollars more”): and would “a fistful of dollars” make any difference?

“…However, in the grand scheme of things, it fails to make an impact on the provision of healthcare at large. The global burden of cardiovascular [2] and respiratory disease [3,4] looms large and has increased in recent years. At a global level, it becomes a formidable challenge to narrow the gap between "supply" and "demand", as far as provision of ECMO services is concerned.…”

Do greenhouse gases impact our respiratory system?: A study of the effect of greenhouse gas emissions on respiratory disease related mortality in Ireland.

“…Among such chronic diseases, respiratory disease poses a major threat to global health [4]. By 2017, around 544•9 million people worldwide had some form of chronic respiratory disease, this is almost an increase of 40% on the 1990 figure [5].…”